DiaMedica Announces Initiation of Phase I/II Clinical Trial for Potential First-in-Class Treatment of Type 2 Diabetes
May 01, 2013
from Marketwired
DiaMedica Receives Phase I/II Clinical Trial Regulatory Approval for DM-199 as a Potential Treatment for Diabetes
April 08, 2013
from Marketwired
from Marketwired
DiaMedica Inc. Announces Filing of Final Prospectus
March 15, 2013
from Marketwired
DiaMedica Inc. Announces Public Offering
February 25, 2013
from Marketwired
DiaMedica Announces Resignation of Board Member
February 22, 2013
from Marketwired
DiaMedica to Present at 15th Annual BIO CEO & Investor Conference
February 05, 2013
from Marketwired
DiaMedica Successfully Completes DM-199 cGMP Manufacturing and Pre-clinical Toxicology Safety Studies
January 29, 2013
from Marketwired
DiaMedica Announces the Appointment of Dr. Mark Robbins as Vice President, Clinical and Regulatory Affairs
January 09, 2013
from Marketwired
DiaMedica Announces Positive DM-199 Pre-Clinical Results Supporting Glucose-Plus Type 2 Diabetes Profile
December 19, 2012
from Marketwired
DiaMedica Announces Opening of U.S. Headquarters
November 01, 2012
from Marketwired
DiaMedica Announces that Co-Administration of DM-199 with Insulin Enhances Insulin's Glucose Lowering Activity
October 16, 2012
from Marketwired
DiaMedica's DM-204 Selected for Late Breaking Poster Presentation at the 2012 American Heart Association's Scientific Conference
September 27, 2012
from Marketwired
DiaMedica Receives $1.7 Million Through Warrant Exercise
September 11, 2012
from Marketwired
DiaMedica Retains the Law Firm Cooley LLP as its Intellectual Property and Corporate Partnering Counsel
August 28, 2012
from Marketwired
DiaMedica Accelerates Warrant Expiry Date
August 03, 2012
from Marketwired
from Marketwired
DiaMedica Announces Summary of DM-204 Program at the 72nd Annual American Diabetes Association Conference
June 14, 2012
from Marketwired
from Marketwired
DiaMedica Issues DSU Units and Grants Stock Options
May 10, 2012
from Marketwired
from Marketwired
DiaMedica Named One of TSX Venture's Top 50 Companies
February 16, 2012
from Marketwired
DiaMedica to Present at the 14th Annual BIO CEO and Investor Conference
February 13, 2012
from Marketwired
DiaMedica's DM-204 for Type 2 Diabetes Successfully Humanized
December 19, 2011
from Marketwired
DiaMedica Announces Formation of Development Advisory Group for Its DM-199 and DM-204 Diabetes Products
November 29, 2011
from Marketwired
Infineta Offers Pay-As-You-Go Data Migration Accelerator
November 14, 2011
category
Networking
Dr. Paul Burn to Join DiaMedica's Scientific Advisory Board
October 27, 2011
from Marketwired
DiaMedica's DM-199 and DM-204 Both Named to Windhover's "2011 Top 10 Cardiovascular/Metabolic Projects to Watch"
October 12, 2011
from Marketwired
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here